Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies

NCT05778279 is registered in ClinicalTrials.gov with Woman's Health University Hospital, Egypt as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05778279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies
Lead sponsor
Woman's Health University Hospital, Egypt
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2024
Completion date
February 1, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anomaly, central nervous system diseases, ultrasound therapy; complications